发明授权
- 专利标题： N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
- 专利标题（中）： N-吡唑啉酮酮乙酰辅酶A羧化酶抑制剂
-
申请号： US12941133申请日： 2010-11-08
-
公开(公告)号： US08288405B2公开(公告)日： 2012-10-16
- 发明人: Scott William Bagley , David Andrew Griffith , Daniel Wei-Shung Kung
- 申请人： Scott William Bagley , David Andrew Griffith , Daniel Wei-Shung Kung
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 代理商 James T. Wasicak
- 主分类号： A61K31/438
- IPC分类号： A61K31/438 ; C07D401/14 ; C07D401/04
摘要：
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3 and R4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
公开/授权文献
- US20110111046A1 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors 公开/授权日：2011-05-12